Mostrar el registro sencillo

dc.contributor.authorLambert, Jean-Charles
dc.contributor.authorZelenika, Diana
dc.contributor.authorHiltunen, Mikko
dc.contributor.authorChouraki, Vincent
dc.contributor.authorCombarros Pascual, Onofre 
dc.contributor.authorBullido, María Jesús
dc.contributor.authorTognoni, Gloria
dc.contributor.authorFiévet, Nathalie
dc.contributor.authorBoland, Anne
dc.contributor.authorArosio, Beatrice
dc.contributor.authorCoto García, Elicer
dc.contributor.authorZompo, Maria del
dc.contributor.authorMateo Fernández, José Ignacio
dc.contributor.authorFrank García, Ana
dc.contributor.authorHelisalmi, Seppo
dc.contributor.authorPorcellini, Elisa
dc.contributor.authorPilotto, Alberto
dc.contributor.authorForti, Paola
dc.contributor.authorFerri, Raffaele
dc.contributor.authorDelepine, Marc
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2015-04-20T07:55:17Z
dc.date.available2015-04-20T07:55:17Z
dc.date.issued2011-04
dc.identifier.issn0197-4580
dc.identifier.urihttp://hdl.handle.net/10902/6222
dc.description.abstractRecent genome-wide association studies have identified five loci (BIN1, CLU, CR1, EXOC3L2 and PICALM) as genetic determinants of Alzheimer’s disease (AD). We attempted to confirm the association between these genes and the AD risk in three contrasting European populations (from Finland, Italy and Spain). Since CLU and CR1 had already been analyzed in these populations, we restricted our investigation to BIN1, EXO2CL3 and PICALM. In a total of 2,816 AD cases and 2,706 controls, we unambiguously replicated the association of rs744373 (for BIN1) and rs541458 (for PICALM) polymorphisms with the AD risk (OR=1.26, 95% CI [1.15-1.38], p=2.9x10-7, and OR=0.80, 95% CI [0.74-0.88], p=4.6x10-7, respectively). In a meta-analysis, rs597668 (EXOC3L2) was also associated with the AD risk, albeit to a lesser extent (OR=1.19, 95% CI [1.06-1.32], p=2.0x10-3). However, this signal did not appear to be independent of APOE. In conclusion, we confirmed that BIN1 and PICALM are genetic determinants of AD, whereas the potential involvement of EXOC3L2 requires further investigation.es_ES
dc.format.extent13 p.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rights© Elsevier. NOTICE: this is the author’s version of a work that was accepted for publication in Neurobiology of Aging. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Neurobiology of Aging. 2011 Apr;32(4):756.e11-5. doi: 10.1016/j.neurobiolaging.2010.11.022.es_ES
dc.sourceNeurobiology of Aging. 2011 Apr;32(4):756.e11-5es_ES
dc.titleEvidence of the association of BIN1 and PICALM with the AD risk in contrasting European populationses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttp://www.sciencedirect.com/science/article/pii/S0197458010005154es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1016/j.neurobiolaging.2010.11.022
dc.type.versionacceptedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo